Since the initial identification of the microtubule motor proteins kinesin and cytoplasmic dynein in the late 1980s, there has been tremendous progress in exploring the molecular mechanisms leading to force production. Application of state-of-the-art biophysical approaches has allowed for the analysis of motor function with single-molecule precision [1] . Recent progress has also begun to address the mechanisms leading to motor coordination when multiple motor types are bound to the same vesicular cargo [2, 3] .
In contrast, there has been much less rapid progress in our understanding of how unidirectional motors are effectively regulated in the cell, especially within the context of the neuron. Basic questions in regard to transport along the axon remain unanswered -how does the cell specifically activate plus-end-directed motors, primarily members of the kinesin superfamily, to drive motility of vesicles outward along the axon? Once these motors reach their destination, are they switched off? Or are they preferentially degraded at the distal end of the axon? Regulation of the primary minus-end-directed motor in neurons, cytoplasmic dynein, is even less well understood. Dynein may be passively transported outward as a cargo of kinesin, and then specifically activated distally in order to drive transport of vesicles and organelles back to the cell body.
The questions become more complex when you consider that outward transport from the cell body to neuronal processes also involves sorting -some cargos are specifically targeted to the axon, some to dendrites, and some undergo a form of transcytosis in order to reach their correct cellular destinations. The mechanisms that regulate this sorting are under active investigation and may involve differences in motor properties, cargo-specific targeting, or differential post-translational modifications of the microtubule cytoskeleton [4] . Underlying these differences are potentially critical distinctions in microtubule organization. In mammalian neurons, microtubules are oriented with a uniform polarity in axons (plus ends outward) and a mixed polarity in dendrites. The unipolar organization of microtubules in the axon is generally conserved across species, but dendritic organization may be more variable. Recent work has shown that in Drosophila, dendritic microtubules may be uniformly polarized, but with plus ends directed inward [5] .
Given the central importance of the establishment and maintenance of cell polarity in normal neuronal function, it is remarkable how poorly we understand the regulation of intracellular transport in the neuron. Some progress has been made in defining the regulatory mechanisms that control kinesin activity [6] , but much less is known about the regulation of cytoplasmic dynein [7] . Specifically, an 'on/off' switch for dynein motor activity has not yet been identified. Now, a recent study by Ou et al. [8] uses genetic approaches to provide new insights into the regulation of dynein in motor neurons and is likely to accelerate research in this area.
Using Caenorhabditis elegans to perform an unbiased genetic screen, Ou et al. [8] examined cholinergic motor neurons from mutagenized worms for the abnormal redistribution of presynaptic markers to dendritic processes. They identified two novel mutants that develop normally, with generally normal axonal and dendritic morphology, yet show pronounced mislocalization of specific presynaptic markers, including RAB-3 and SYD-2/ liprin-a. These markers are normally restricted to axons, yet show a distinct localization to dendrites as well in the two mutant strains. Mapping and sequence analysis led to the identification of the mutant genes as pct-1, which encodes Pctaire, a member of the cyclin-dependent kinase (CDK) family, and cyy-1, which encodes a cyclin. Genetic studies suggest that these two genes function in the same pathway; in vitro studies indicate that CYY-1 can activate the kinase activity of PCT-1.
While CDKs are best known for their roles in the regulation of cell division, this is not the first time that they have been linked to the regulation of intracellular transport. Previous work has implicated CDK-5 in the regulation of trafficking in the neuron [9] . The current study [8] supports a role for CDK-5 in trafficking in the neuron, as a null mutation in cdk-5 or its activator cdka-1/p35 leads to a mislocalization of presynaptic proteins to dendrites that resembles that seen in the newly described pct-1 and cyy-1 mutant worms. While all four genes function in a cell-autonomous manner, they act in two parallel pathways, as the cdk-5; pct-1 double mutants are more severely affected than either of the single mutants.
The mutations affect the trafficking of only a subset of intracellular cargos. Multiple dendritic markers are correctly localized, and the axonal distribution of mitochondria is not altered in the cyy-1; cdk-5 double mutants. Live imaging of the motility of GFP-labeled RAB-3 puncta moving along the axon indicates that, in wild-type neurons, 76% of movement is anterograde and 24% is retrograde. In the double cyy-1; pct-1 mutants, the number of vesicles with anterograde movement is not markedly altered, but there is a significant approximately twofold increase in the number of vesicles moving in the retrograde direction.
Together, these observations suggest that both of the CDKs under investigation, PCT-1 and CDK-5, may act to inhibit dynein. Ou et al. [8] test this hypothesis by showing that mutations in cytoplasmic dynein or in the dynein-binding protein NUD-2, the worm ortholog of the mammalian dynein-interacting proteins NudE and NudEL, suppress the dendritic mislocalization phenotype of the cdk-5 or pct-1 mutations.
So the new work suggests a paradigm for the regulation of axonal transport, in which the activity of either CDK -CDK-5 or PCT-1 -inhibits the motor activity of dynein (Figure 1 ). This in turn will lead to the dominance of the anterograde motor, which for the cargos under investigation by Ou et al. [8] is the kinesin family member UNC-104. In wild-type neurons, UNC-104 activity, unopposed by dynein, will lead to the efficient localization of synaptic vesicle precursor proteins such as RAB-3 to the synapse. But in the mutant worms, inappropriate dynein activity leads to a mislocalization of these cargos to dendrites. Recent work has shown that dynein can drive cargo selectively into dendrites [10] , consistent with this observation.
This is a valuable model that raises a number of interesting questions. First, at a technical level, it would be useful to have a clearer demonstration that the normal organization of microtubules is not altered in the affected neurons, as alterations in dynein function have been shown to affect microtubule polarity [11] ; posttranslational modifications of the microtubule cytoskeleton may also be affected in the mutant strains. Similarly, the work could be extended by examining the localization or mislocalization of additional cargos.
Further, the molecular mechanisms involved are yet to be determined -is dynein a substrate for either the CDK-5 or PCT-1 kinases, or does the mechanism involve additional regulatory molecules, such as NudE? Interestingly, a recent in vitro study has shown that NudE binding inhibits dynein motor function [12] , consistent with a role for this protein in a negative regulatory pathway.
One very intriguing observation from the study by Ou et al. [8] is that the phenotype is seen in only a subset of motor neurons, even in the double cdk-5; pct-1 mutant worms. This suggests that both of these regulatory pathways are redundant with other regulatory mechanisms that can effectively regulate microtubule motor function in unaffected neurons. This is interesting for at least two reasons. The first is that it means that we still have a lot to learn about the pathways that regulate trafficking along cellular microtubules. The second is that this cell-type-specific effect may provide some further insights into the cell-type specificity of human genetic diseases.
One currently unanswerable question in regard to many of the neurodegenerative disease genes under investigation is why they affect only certain populations of neurons. For example, differential mutations in dynactin, a required activator of the cytoplasmic dynein motor, affect two distinct populations of neurons [13, 14] . The mechanisms by which mutations in the same domain of a ubiquitously expressed protein can differentially affect distinct neuronal populations remains to be determined, but the observations reported here suggest that differential regulation of dynein activity may at least partially compensate for defective motor function. This is only one possibility, but it makes it clear that the observations of Ou et al. [8] Figure 1 . Model for the negative regulation of the microtubule motor cytoplasmic dynein in neurons by the CDK PCT-1. In axons, microtubule plus ends are oriented outward and microtubule minus ends are oriented toward the centrosome in the cell body. These microtubules serve as tracks for the minus-enddirected motor cytoplasmic dynein to drive transport toward the cell soma. In dendrites, where microtubule polarity may be mixed, dynein has the potential to drive cargos outward as well as inward [10] . The new study from Ou et al. [8] suggests that the negative regulation of dynein motor activity by the CDK PCT-1 may prevent the inappropriate trafficking of axonal cargos into dendrites. In a C. elegans pct-1 mutant, axonal cargos, including RAB-3 and SYD-2/liprin-a, are mislocalized into the dendrites of some motor neurons. The related CDK, CDK-5, may play a similar role in negatively regulating dynein, but localization studies suggest that CDK-5 is primarily localized to axons while PCT-1 activity may be highest in dendrites.
